Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Corina Ciobanasu. (2021) Peptides-based therapy and diagnosis. Strategies for non-invasive therapies in cancer. Journal of Drug Targeting 29:10, pages 1063-1079.
Read now
Read now
Lingaku Lee, Tetsuhide Ito & Robert T. Jensen. (2018) Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies. Expert Review of Anticancer Therapy 18:9, pages 837-860.
Read now
Read now
Articles from other publishers (37)
Benjamin E. White, Brian Rous, Kandiah Chandrakumaran, Kwok Wong, Catherine Bouvier, Mieke Van Hemelrijck, Gincy George, Beth Russell, Rajaventhan Srirajaskanthan & John K. Ramage. (2022) Incidence and survival of neuroendocrine neoplasia in England 1995–2018: A retrospective, population-based study. The Lancet Regional Health - Europe 23, pages 100510.
Crossref
Crossref
Giulia Poletto, Diego Cecchin, Stefania Sperti, Luca Filippi, Nicola Realdon & Laura Evangelista. (2022) Head-to-Head Comparison between Peptide-Based Radiopharmaceutical for PET and SPECT in the Evaluation of Neuroendocrine Tumors: A Systematic Review. Current Issues in Molecular Biology 44:11, pages 5516-5530.
Crossref
Crossref
Mai Lin, Ryan P. Coll, Allison S. Cohen, Dimitra K. Georgiou & Henry Charles Manning. (2022) PET Oncological Radiopharmaceuticals: Current Status and Perspectives. Molecules 27:20, pages 6790.
Crossref
Crossref
Nasim Vahidfar, Saeed Farzanehfar, Mehrshad Abbasi, Siroos Mirzaei, Ebrahim S. Delpassand, Farzad Abbaspour, Yalda Salehi, Hans Jürgen Biersack & Hojjat Ahmadzadehfar. (2022) Diagnostic Value of Radiolabelled Somatostatin Analogues for Neuroendocrine Tumour Diagnosis: The Benefits and Drawbacks of [64Cu]Cu-DOTA-TOC. Cancers 14:8, pages 1914.
Crossref
Crossref
Mai Lin, Dao B. Le & Homer A. Macapinlac. 2022. Nuclear Medicine and Molecular Imaging. Nuclear Medicine and Molecular Imaging
557
564
.
Natalia Herrero Álvarez, David Bauer, Javier Hernández‐Gil & Jason S. Lewis. (2021) Recent Advances in Radiometals for Combined Imaging and Therapy in Cancer. ChemMedChem 16:19, pages 2909-2941.
Crossref
Crossref
Sanjoy Das & Malay K. Das. 2021. Multifunctional Theranostic Nanomedicines in Cancer. Multifunctional Theranostic Nanomedicines in Cancer
307
344
.
Maximilian Klingler, Anton Amadeus Hörmann & Elisabeth Von Guggenberg. (2020) Cholecystokinin-2 Receptor Targeting with Radiolabeled Peptides: Current Status and Future Directions. Current Medicinal Chemistry 27:41, pages 7112-7132.
Crossref
Crossref
Siroos Mirzaei & Rainer W. Lipp. (2020) Peptide and pseudo-peptide. The Quarterly Journal of Nuclear Medicine and Molecular Imaging 64:4.
Crossref
Crossref
Outi Keinänen, Kimberly FungJames M. BrennanNicholas ZiaMatt HarrisEllen van Dam, Colin BigginAmos HedtJon StonerPaul S. Donnelly, Jason S. Lewis & Brian M. Zeglis. (2020)
Harnessing
64
Cu/
67
Cu for a theranostic approach to pretargeted radioimmunotherapy
. Proceedings of the National Academy of Sciences 117:45, pages 28316-28327.
Crossref
Crossref
Esben Andreas Carlsen, Camilla Bardram Johnbeck, Tina Binderup, Mathias Loft, Andreas Pfeifer, Jann Mortensen, Peter Oturai, Annika Loft, Anne Kiil Berthelsen, Seppo W. Langer, Ulrich Knigge & Andreas Kjaer. (2020)
64
Cu-DOTATATE PET/CT and Prediction of Overall and Progression-Free Survival in Patients with Neuroendocrine Neoplasms
. Journal of Nuclear Medicine 61:10, pages 1491-1497.
Crossref
Crossref
Benjamin Poret, Laurence Desrues, Marc-André Bonin, Martin Pedard, Martine Dubois, Richard Leduc, Romain Modzelewski, Pierre Decazes, Fabrice Morin, Pierre Vera, Hélène Castel, Pierre Bohn & Pierrick Gandolfo. (2020) Development of Novel 111-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours. Biomolecules 10:3, pages 471.
Crossref
Crossref
M. Suárez-Piñera, L. Visa, L. Ilzarbe, A. Zugazaga, I. Poves, A. Mestre-Fusco & M. Iglesias. (2019) PET/CT imaging with somatostatin analogues for the assessment of neuroendocrine tumours, initial experience. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 38:6, pages 382-385.
Crossref
Crossref
M. Suárez-Piñera, L. Visa Turno, L. Ilzarbe, A. Zugazaga, I. Poves, A. Mestre-Fusco & M. Iglesias. (2019) PET/TC con análogos de la somatostatina en el estudio de tumores neuroendocrinos, experiencia inicial. Revista Española de Medicina Nuclear e Imagen Molecular 38:6, pages 382-385.
Crossref
Crossref
Outi Keinänen, James M. Brennan, Rosemery Membreno, Kimberly Fung, Kishore Gangangari, Eric J. Dayts, Carter J. Williams & Brian M. Zeglis. (2019) Dual Radionuclide Theranostic Pretargeting. Molecular Pharmaceutics 16:10, pages 4416-4421.
Crossref
Crossref
Martin Biermann. (2019)
PET/CT with [
68
Ga]DOTANOC Is More Sensitive Than [
18
F]FDG for Restaging of Metastatic Medullary Thyroid Cancer
. Clinical Thyroidology 31:9, pages 392-395.
Crossref
Crossref
Angela Carollo, Stefano Papi, Chiara M. Grana, Luigi Mansi & Marco Chinol. (2019) State of the Art and Recent Developments of Radiopharmaceuticals for Pancreatic Neuroendocrine Tumors Imaging. Current Radiopharmaceuticals 12:2, pages 107-125.
Crossref
Crossref
Mingru Zhang, Orit Jacobson, Dale O. Kiesewetter, Ying Ma, Zhantong Wang, Lixin Lang, Longguang Tang, Fei Kang, Hongzhang Deng, Weijing Yang, Gang Niu, Jing Wang & Xiaoyuan Chen. (2019) Improving the Theranostic Potential of Exendin 4 by Reducing the Renal Radioactivity through Brush Border Membrane Enzyme-Mediated Degradation. Bioconjugate Chemistry 30:6, pages 1745-1753.
Crossref
Crossref
Atsushi Ishizaki, Kenji Mishiro, Kazuhiro Shiba, Hirofumi Hanaoka, Seigo Kinuya, Akira Odani & Kazuma Ogawa. (2019) Fundamental study of radiogallium-labeled aspartic acid peptides introducing octreotate derivatives. Annals of Nuclear Medicine 33:4, pages 244-251.
Crossref
Crossref
A. V. Alekberzade, N. N. Krylov, E. M. Lipnitskiy, R. O. Shakhbazov & F. Azari. (2019) Gastric neuroendocrine tumors. Khirurgiya. Zhurnal im. N.I. Pirogova:12, pages 111.
Crossref
Crossref
Faidon-Marios Laskaratos & Martyn Caplin. (2019) Treatment challenges in and outside a network setting: Gastrointestinal neuroendocrine tumours. European Journal of Surgical Oncology 45:1, pages 52-59.
Crossref
Crossref
Ferdinand Seith, Christina Schraml, Gerald Reischl, Konstantin Nikolaou, Christina Pfannenberg, Christian la Fougère & Nina Schwenzer. (2018) Fast non-enhanced abdominal examination protocols in PET/MRI for patients with neuroendocrine tumors (NET): comparison to multiphase contrast-enhanced PET/CT. La radiologia medica 123:11, pages 860-870.
Crossref
Crossref
Theodora Chatzisideri, George Leonidis & Vasiliki Sarli. (2018) Cancer-targeted delivery systems based on peptides. Future Medicinal Chemistry 10:18, pages 2201-2226.
Crossref
Crossref
Ulrich Knigge, Mikkel Andreassen, Birgitte Federspiel, Carsten Palnæs Hansen, Andreas Kjær & Seppo W. Langer. 2018. Encyclopedia of Endocrine Diseases. Encyclopedia of Endocrine Diseases
626
634
.
David C Metz, Guillaume Cadiot, Pierre Poitras, Tetsuhide Ito & Robert T Jensen. (2017) Diagnosis of Zollinger–Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing. International Journal of Endocrine Oncology 4:4, pages 167-185.
Crossref
Crossref
Jules Zhang-Yin, Anne-Sophie Dirand, Myriam Sasanelli, Gwenaelle Corrégé, Aude Peudon, Thierry Kiffel, Valérie Nataf, Jérôme Clerc, Françoise Montravers & Jean-Noël Talbot. (2017) Equivalent Dose Rate 1 Meter from Neuroendocrine Tumor Patients Exiting the Nuclear Medicine Department After Undergoing Imaging. Journal of Nuclear Medicine 58:8, pages 1230-1235.
Crossref
Crossref
Philipp M. Kazmierczak, Axel Rominger, Vera Wenter, Christine Spitzweg, Christoph Auernhammer, Martin K. Angele, Carsten Rist & Clemens C. Cyran. (2016) The added value of 68Ga-DOTA-TATE-PET to contrast-enhanced CT for primary site detection in CUP of neuroendocrine origin. European Radiology 27:4, pages 1676-1684.
Crossref
Crossref
Martin Biermann. (2017) Prostate-Specific Membrane Antigen Expression in Metastasized Iodine-Negative Thyroid Cancer May Provide a Novel Therapeutic Approach. Clinical Thyroidology 29:3, pages 94-96.
Crossref
Crossref
Pedro A.A de Castro, Derly Augusto Dias, Marcelo Noronha Veloso & Denise Maria Zezell. (2017) Biochemical Evaluation of Bone Submitted to Ionizing Radiation by ATR-FTIR Spectroscopy. Biochemical Evaluation of Bone Submitted to Ionizing Radiation by ATR-FTIR Spectroscopy.
A. Tuba Kendi, Valeria M. Moncayo, Jonathon A. Nye, James R. Galt, Raghuveer Halkar & David M. Schuster. (2017) Radionuclide Therapies in Molecular Imaging and Precision Medicine. PET Clinics 12:1, pages 93-103.
Crossref
Crossref
Gabriele Pöpperl & Clemens Cyran. 2019. Multislice CT. Multislice CT
675
689
.
Camilla B. Johnbeck, Ulrich Knigge, Seppo W. Langer, Annika Loft, Anne Kiil Berthelsen, Birgitte Federspiel, Tina Binderup & Andreas Kjaer. (2016)
Prognostic Value of
18
F-FLT PET in Patients with Neuroendocrine Neoplasms: A Prospective Head-to-Head Comparison with
18
F-FDG PET and Ki-67 in 100 Patients
. Journal of Nuclear Medicine 57:12, pages 1851-1857.
Crossref
Crossref
Jan Müller, Robin Reichel, Sebastian Vogt, Stefan P. Müller, Wolfgang Sauerwein, Wolfgang Brandau, Angelika Eggert & Alexander Schramm. (2016) Identification and Tumour-Binding Properties of a Peptide with High Affinity to the Disialoganglioside GD2. PLOS ONE 11:10, pages e0163648.
Crossref
Crossref
Harshad R. Kulkarni, Aviral Singh & Richard P. Baum. (2016) Advances in the Diagnosis of Neuroendocrine Neoplasms. Seminars in Nuclear Medicine 46:5, pages 395-404.
Crossref
Crossref
Paola PanichelliCarlo VillanoAngelina CistaroAndrea BrunoFrancesco BarbatoArnoldo PiccardoAdriano Duatti. (2016) Imaging of Brain Tumors with Copper-64 Chloride: Early Experience and Results. Cancer Biotherapy and Radiopharmaceuticals 31:5, pages 159-167.
Crossref
Crossref
Luca Filippi, Francesco Scopinaro, Giuseppe Pelle, Roberto Cianni, Rita Salvatori, Orazio Schillaci & Oreste Bagni. (2015) Molecular response assessed by 68Ga-DOTANOC and survival after 90Y microsphere therapy in patients with liver metastases from neuroendocrine tumours. European Journal of Nuclear Medicine and Molecular Imaging 43:3, pages 432-440.
Crossref
Crossref
Ferdinand Seith, Sergios Gatidis, Sotirios Bisdas, Christian la Fougère, Jürgen Schäfer, Konstantin Nikolaou & Nina Schwenzer. (2015) PET/MR in Oncology. Current Radiology Reports 3:10.
Crossref
Crossref